Delivery Order SPE2DB22D3102-SPE2DB24FL2NE

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Glipizide ER 10 mg tablets in quantities of 1,000 per order. The $4,261.23 contract was awarded by the Defense Logistics Agency (DLA), a major logistics and acquisition agency supporting the Department of Defense, and has a completion date of May 6, 2024. Amerisourcebergen, a leading pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued at up to...
This is a delivery order worth $5,611.35 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The order is for the supply of 4,565,318 units of Glipizide ER 10 mg tablets, a prescription medication. The contract has an ultimate completion date of August 2, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,814.40 firm-fixed-price delivery order is for the supply of 4,564,895,994 glipizide ER 10 mg tablets. Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of GLIPIZIDE ER 10 MG TABLET 500S. The $4,912.99 firm fixed-price delivery order has a completion date of November 12, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,281.71 delivery order contract is for the supply of GLIPIZIDE ER 10 MG TABLET 500S, with a period of performance through July 1, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract between Amerisourcebergen and the DLA Troop Support Medical, which facilitates the procurement of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a leading pharmaceutical distributor. The $3,675.32 Firm Fixed Price delivery order is for the supply of 4,564,836,203 Glipizide ER 10 mg tablets. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department...
This federal contract award, valued at $4,256.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4,563,814,309 tablets of Glipizide ER 10 mg, a medication used to treat diabetes. The contract has a firm fixed price and an ultimate completion date of March 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,559 units of the pharmaceutical product Glipizide ER 10 mg tablets. The $4,974.55 Firm Fixed Price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,103.28, is a Firm Fixed Price Delivery Order for the supply of GLIPIZIDE ER 10 MG TABLET 500S. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. The company...
This is a firm fixed-price delivery order under contract SPE2DX15D1205 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,509.18 award is for 1,000 tablets of Glipizide ER 10 mg, a medication used to treat diabetes. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract with the DLA, which provides a comprehensive range of...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL2NE
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Glipizide ER 5 mg tablets. The fixed-price delivery order, valued at $1,360.48, has an ultimate completion date of August 15, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and medical supplies to support military, veteran, and other government healthcare programs nationwide.

Generated 11/13/24, 9:25 AM